MicroRNAs with multiple targets of immune checkpoints, as a potential sensitizer for immune checkpoint inhibitors in breast cancer treatment
H Zhou, W Jia, L Lu, R Han - Cancers, 2023 - mdpi.com
Simple Summary Based on the latest research progresses, application of immune
checkpoint inhibitors (ICIs) has shown promise in treating breast cancer. Moreover, novel …
checkpoint inhibitors (ICIs) has shown promise in treating breast cancer. Moreover, novel …
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer
S Torres-Esquius, A Llop-Guevara… - JAMA Network …, 2024 - jamanetwork.com
Importance RAD51CandRAD51Dare involved in DNA repair by homologous recombination.
Germline pathogenic variants (PVs) in these genes are associated with an increased risk of …
Germline pathogenic variants (PVs) in these genes are associated with an increased risk of …
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making
F Perrone, F Facchinetti, B Pellegrino… - Tumori …, 2024 - journals.sagepub.com
Introduction: Several biomarkers are currently available to address targeted treatments in
cancer patients, with lung malignancies representing one of the best examples. Case …
cancer patients, with lung malignancies representing one of the best examples. Case …
[PDF][PDF] Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer
M Romey, G Llort, S Torres-Esquius, A Llop-Guevara… - 2024 - scientiasalut.gencat.cat
Importance RAD51C and RAD51D are involved in DNA repair by homologous
recombination. Germline pathogenic variants (PVs) in these genes are associated with an …
recombination. Germline pathogenic variants (PVs) in these genes are associated with an …